<DOC>
	<DOCNO>NCT01126255</DOCNO>
	<brief_summary>This randomized trial compare progesterone conventional clobetasol propionate patient vulvar lichen sclerosus .</brief_summary>
	<brief_title>Progesterone v Clobetasol Propionate Vulvar Lichen Sclerosus</brief_title>
	<detailed_description>Background A total 62 female patient first diagnosis lichen sclerosus treat daily either topical progesterone 8 % clobetasol propionate 0.05 % 12 week . Response treatment evaluate macroscopic description dermatologic phenotype use specific lichen sclerosus score photography-documentation . The symptom quality life patient evaluate standardized questionnaire . Additionally , tissue sample take 12 week treatment evaluate response status . Objective The purpose study compare progesterone conventional clobetasol propionate superiority trial . Methods Prospective , randomize , control , superiority phase II pilot trial . Patients randomize 1:1 either progesterone clobetasol propionate , patient , physician , assessor analyst blind .</detailed_description>
	<mesh_term>Lichen Sclerosus et Atrophicus</mesh_term>
	<mesh_term>Vulvar Lichen Sclerosus</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Signed informed consent Consent biopsy start end therapy Suspicion Lichen sclerosus Premenopausal Age â‰¥18 year Exclusion Criteria Prior surgery vulva , exception episiotomy Pregnancy Signs infection human papilloma virus vulva Vulvar intraepithelial neoplasia ( VIN ) Known generalise autoimmune disease Lichen sclerosus since childhood Prior therapy topic clobetasol propionate immunosuppressive ( tacrolimus pimecrolimus ) vulva Atopic diathesis and/or contact allergy Systemic immunosuppressive therapy Genital infection within last four week ( eg. , condyloma acuminata , candidiasis )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>vulvar lichen sclerosus</keyword>
	<keyword>progesterone</keyword>
	<keyword>clobetasol</keyword>
	<keyword>randomize control trial</keyword>
</DOC>